BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 12892510)

  • 1. Photodynamic therapy for the treatment of skin disease.
    Kendall CA; Morton CA
    Technol Cancer Res Treat; 2003 Aug; 2(4):283-8. PubMed ID: 12892510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy for non-melanoma skin cancer.
    Fien SM; Oseroff AR
    J Natl Compr Canc Netw; 2007 May; 5(5):531-40. PubMed ID: 17509255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The wider application of photodynamic therapy in dermatology].
    Thissen MR; Kuijpers DI; Neumann HA
    Ned Tijdschr Geneeskd; 2005 Jan; 149(5):232-7. PubMed ID: 15719833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?
    Morton CA
    J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.
    Morton CA; Brown SB; Collins S; Ibbotson S; Jenkinson H; Kurwa H; Langmack K; McKenna K; Moseley H; Pearse AD; Stringer M; Taylor DK; Wong G; Rhodes LE
    Br J Dermatol; 2002 Apr; 146(4):552-67. PubMed ID: 11966684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
    Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
    J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and research applications of photodynamic therapy in dermatology: experience of the Scottish PDT Centre.
    Moseley H; Ibbotson S; Woods J; Brancaleon L; Lesar A; Goodman C; Ferguson J
    Lasers Surg Med; 2006 Jun; 38(5):403-16. PubMed ID: 16788933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
    Harth Y; Hirshovitz B
    Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy for nonmelanoma skin cancers. Current review and update.
    Zeitouni NC; Oseroff AR; Shieh S
    Mol Immunol; 2003 Jul; 39(17-18):1133-6. PubMed ID: 12835091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European guidelines for topical PDT part 1 JEADV 2013; 27: 536-544.
    Skaria AM
    J Eur Acad Dermatol Venereol; 2014 May; 28(5):673. PubMed ID: 23981061
    [No Abstract]   [Full Text] [Related]  

  • 12. Photodynamic therapy in dermatology.
    Nayak CS
    Indian J Dermatol Venereol Leprol; 2005; 71(3):155-60. PubMed ID: 16394402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
    Morton CA
    Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminolevulinic acid photodynamic therapy for skin cancers.
    Blume JE; Oseroff AR
    Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma.
    Morton CA; Szeimies RM; Sidoroff A; Braathen LR
    J Eur Acad Dermatol Venereol; 2013 May; 27(5):536-44. PubMed ID: 23181594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology].
    Basset-Seguin N
    Ann Dermatol Venereol; 2013 Nov; 140 Suppl 2():223-8. PubMed ID: 24199714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity.
    Akita Y; Kozaki K; Nakagawa A; Saito T; Ito S; Tamada Y; Fujiwara S; Nishikawa N; Uchida K; Yoshikawa K; Noguchi T; Miyaishi O; Shimozato K; Saga S; Matsumoto Y
    Br J Dermatol; 2004 Aug; 151(2):472-80. PubMed ID: 15327557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotlighting the role of photodynamic therapy in cutaneous malignancy: an update and expansion.
    Ross K; Cherpelis B; Lien M; Fenske N
    Dermatol Surg; 2013 Dec; 39(12):1733-44. PubMed ID: 24118243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to Letter to the editor: 'European guidelines for topical PDT part 1. JEADV 2013;27:536-544' DOI: 10.1111/jdv.12258.
    Morton CA; Szeimies RM; Sidoroff A; Braathen LR
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1451-2. PubMed ID: 24666245
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.
    Cabete J; Rafael M; Cravo M; Moura C; Sachse F; Pecegueiro M
    An Bras Dermatol; 2015; 90(6):846-50. PubMed ID: 26734866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.